This course covers Concentration Risk in Collateral Portfolio, which involves assessing exposure concentration across issuers, sectors, industries, and correlated securities within pledged collateral portfolios supporting Loan Against Shares (LAS) Credit exposures, within Loan Against Shares (LAS) Credit. It applies to accounts requiring structured assessment, clear boundary definition, and independent review before any credit action is finalized.
It evaluates key dimensions such as assessment of exposure concentration across issuers to identify excessive dependency on individual companies or promoter-linked entities within pledged collateral pools, evaluation of sector and industry concentration risk to determine vulnerability to sector-specific downturns or market stress events, analysis of correlated scrips within the pledged portfolio to assess contagion risk arising from highly interconnected or similarly behaving securities, and issuer-level risk assessment to evaluate the financial strength, market stability, and liquidity profile of concentrated collateral positions, with each requiring independent validation and documented rationale to ensure concentration exposure remains identifiable, measurable, and aligned with approved collateral and portfolio risk governance standards.
It is distinct from portfolio diversification strategy, as it focuses specifically on identification, measurement, and control of concentration and correlation risks within LAS collateral portfolios, rather than broader strategic diversification objectives across enterprise-wide investment or lending portfolios—each governed by separate evidence standards, ownership, and approval authority.
Within Portfolio Concentration & Correlation Risk, the credit analyst executes the assessment, completes documentation, and flags exceptions for manager review within Loan Against Shares (LAS) Credit, directly influencing escalation scope and credit committee prioritization.